Dermata Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Dermata Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Dermata Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $6.69M, a 8.69% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$6.69M	-$636K	-8.69%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$5.24M	-$3.48M	-39.9%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$5.18M	-$4.12M	-44.3%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$7.98M	+$1.03M	+14.9%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$7.32M	-$1.65M	-18.4%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$8.71M	-$2.31M	-21%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$9.3M	+$251K	+2.78%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$6.94M	-$4.68M	-40.3%	Dec 31, 2022	10-K	2024-03-21
Q3 2022	$8.97M	-$4.71M	-34.4%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$11M	+$9.89M	+870%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$9.04M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$11.6M	+$11M	+1820%	Dec 31, 2021	10-K	2023-02-21
Q3 2021	$13.7M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$1.14M			Jun 30, 2021	10-Q	2021-09-27
Q4 2020	$605K			Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.